A combined MOON (Multi-Center Orthopaedic Outcomes Network)- MARS (Multi-Center ACL Revision Study) looked at patellofemoral (kneecap) cartilage changes after allograft or autograft primary ACL reconstruction as identified at the time of revision ACL reconstruction. This study presented by Robert Magnussen of Ohio St. at the Toronto AOSSM (American Orthopaedic Society for Sports Medicine) meeting in July. 134 patients had undergone MOON primary ACL reconstruction followed by MARS revision ACL reconstruction. Progression was identified as progression of one grade worse or a 25% increase in size of the lesion. 31 (23%) had worsening progression of arthritis. Results showed allografts had a 15.5 times higher risk of progression. Odds also increased 10% with each unit increase of BMI. Age, sex, activity level, meniscus status, injury mechanism had no impact. The association between graft choice and damage was surprising. Previously it was thought maybe a patellar tendon (BTB) autograft might be at more riskk. Allografts with more laxity may place more pressure on cartilage, but we cannot be sure. Further work will be necessary to sort this out.
Rick Wright, MD, the author of this blog, is a sports medicine physician at Washington University Orthopedics in St. Louis and the head team physician for the St. Louis Blues. He specializes in the treatment of sports-related injuries, and has special interests in knee ACL and revision ACL injuries, meniscus injuries, articular cartilage injuries of the knee, shoulder instability, rotator cuff disease, and total knee replacements. Your comments and feedback are encouraged.
Monday, September 11, 2017
MOON-MARS Revision ACL Graft Study Presented Toronto AOSSM Meeting
Subscribe to: Post Comments (Atom)
Post a Comment